2023-03-01 2024-02-29 false Capium Accounts Production 1.1 13219804 bus:AbridgedAccounts 2023-03-01 2024-02-29 13219804 bus:FRS102 2023-03-01 2024-02-29 13219804 bus:AuditExempt-NoAccountantsReport 2023-03-01 2024-02-29 13219804 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-29 13219804 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 13219804 2023-03-01 2024-02-29 13219804 2024-02-29 13219804 bus:RegisteredOffice 2023-03-01 2024-02-29 13219804 core:WithinOneYear 2024-02-29 13219804 core:AfterOneYear 2024-02-29 13219804 bus:Director1 2023-03-01 2024-02-29 13219804 bus:Director1 2024-02-29 13219804 bus:Director1 2022-03-01 2023-02-28 13219804 2022-03-01 13219804 bus:LeadAgentIfApplicable 2023-03-01 2024-02-29 13219804 2022-03-01 2023-02-28 13219804 2023-02-28 13219804 core:WithinOneYear 2023-02-28 13219804 core:AfterOneYear 2023-02-28 13219804 bus:EntityAccountantsOrAuditors 2022-03-01 2023-02-28 13219804 bus:OrdinaryShareClass1 2023-03-01 2024-02-29 13219804 bus:OrdinaryShareClass1 2024-02-29 13219804 bus:OrdinaryShareClass1 2022-03-01 2023-02-28 13219804 bus:OrdinaryShareClass1 2023-02-28 13219804 core:InvestmentProperties 2023-03-01 2024-02-29 13219804 core:InvestmentProperties 2024-02-29 13219804 core:InvestmentProperties 2023-02-28 13219804 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-02-29 13219804 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-02-28 13219804 core:CostValuation core:Non-currentFinancialInstruments 2024-02-29 13219804 core:CostValuation core:Non-currentFinancialInstruments 2023-02-28 13219804 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-02-29 13219804 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-02-29 13219804 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-02-29 13219804 core:Non-currentFinancialInstruments 2024-02-29 13219804 core:Non-currentFinancialInstruments 2023-02-28 13219804 core:ShareCapital 2024-02-29 13219804 core:ShareCapital 2023-02-28 13219804 core:RetainedEarningsAccumulatedLosses 2024-02-29 13219804 core:RetainedEarningsAccumulatedLosses 2023-02-28 13219804 dpl:Item1 2023-03-01 13219804 dpl:Item1 2024-02-29 13219804 dpl:Item1 2022-03-01 13219804 dpl:Item1 2023-02-28 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 13219804
England and Wales

 

 

 

KALPH BIO SECURITY LIMITED


Abridged Accounts
 


Period of accounts

Start date: 01 March 2023

End date: 29 February 2024
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Tangible fixed assets 3 291,593   
291,593   
Current assets      
Cash at bank and in hand 6,404    198,004 
Creditors: amount falling due within one year (4,690)   (200)
Net current assets 1,714    197,804 
 
Total assets less current liabilities 293,307    197,804 
Creditors: amount falling due after more than one year (278,610)   (199,010)
Net assets 14,697    (1,206)
 

Capital and reserves
     
Called up share capital 4 1,000    1,000 
Profit and loss account 13,697    (2,206)
Shareholders' funds 14,697    (1,206)
 


For the year ended 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 14 November 2024 and were signed by:


-------------------------------
Nathan BYFORD
Director
1
General Information
Kalph Bio Security Limited is a private company, limited by shares, registered in England and Wales, registration number 13219804, registration address 2nd Floor, Sterling House, Langston Road, Loughton, Essex, IG10 3TS.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
2.

Average number of employees

Average number of employees during the year was 0 (2023 : 0).
3.

Tangible fixed assets

Cost or valuation Investment properties   Total
  £   £
At 01 March 2023  
Additions 291,593    291,593 
Disposals  
At 29 February 2024 291,593    291,593 
Depreciation
At 01 March 2023  
Charge for year  
On disposals  
At 29 February 2024  
Net book values
Closing balance as at 29 February 2024 291,593    291,593 
Opening balance as at 01 March 2023  


4.

Share Capital

Allotted, called up and fully paid
2024
£
  2023
£
1,000 Class A shares of £1.00 each 1,000    1,000 
1,000    1,000 

2